Subscribe Now
Member Sign In
Rewards
Member Sign Out
Sections
About us
Research topics
Membership
Conferences
Webinars
Videos
More
Subscribe
Sign In
Sign Out
Immunology
Antibodies
Vaccines
Immunotherapies
Antibodies
Vaccines
Immunotherapies
Create a FREE account so you can:
Get the latest life sciences research and
industry news, delivered straight to your
inbox, for FREE.
Enter your Email Address to become a member:
Email Address:
Register
Already have an account?
Sign in
Sign in using your social networking account:
What's this?
Sign in using your social networking
account:
(What's this?)
|
Potential treatment for rare autoimmune disorder adapted from CAR-T therapy in study
Evidence from a small-scale clinical trial suggests that a variation of the blood cancer immunotherapy chimeric antigen receptor T-cell (CAR-T) could be adapted to treat myasthenia gravis (MG), an autoimmune disorder of the nervous system.
Read More
Eli Lilly acquiring immune therapy developer Dice Therapeutics for $2.4B
Eli Lilly said this week it has inked an agreement to acquire Dice Therapeutics, a biopharma firm developing novel oral therapeutic candidates, for $2.4 billion in cash.
Read More
1
Conferences
More Conferences »»
Science Briefs
More articles »
Member Rewards
Earn points for contributing to market research. Redeem your points for merchandise, travel, or even to help your favorite charity.
Learn More
Research Topics
Interact with an engaged, global community of your peers who come together to discuss their work and opportunities.
Learn More
Connect
Tweets by @ScienceBoard